FDA grants clearance to Prilenia and Ferrer’s Phase III ALS therapy trial
The study will be carried out at up to 60 ALS treatment centres across Canada, the EU, the US, Israel and the UK.
Clinical Trials
Lindus Health and Quotient Sciences to support sponsors with trial recruitment
UK MHRA clears Ensoma’s EN-374 trial application for X-CGD
EpilepsyGTx secures $33m to progress FRE therapy through Phase I/IIa trials
Novartis reports positive data from VAYHIT2 trial for immune thrombocytopenia
Daiichi Sankyo announces first patient dosed in Phase III trial of Enhertu
Structure Therapeutics announces positive results from aleniglipron trial
Citryll doses first patient in Citylights trial for hidradenitis suppurativa
